You have 9 free searches left this month | for more free features.

dorzolamide-timolol

Showing 1 - 25 of 247

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Glaucoma, Open-Angle, Ocular Hypertension Trial in Argentina (Dorzolamide / Timolol Ophthalmic Solution, dorzolamide/timolol)

Recruiting
  • Glaucoma, Open-Angle
  • Ocular Hypertension
  • Olivos, Buenos Aires, Argentina
  • +5 more
May 10, 2023

Glaucoma, Open-Angle, Ocular Hypertension Trial in Monterrey (Dorzolamide-timolol-brimonidine and latanoprost,

Recruiting
  • Glaucoma, Open-Angle
  • Ocular Hypertension
  • Dorzolamide-timolol-brimonidine and latanoprost
  • Dorzolamide-timolol and latanoprost
  • Monterrey, Mexico
    Servicios Médicos y de Investigación Clínica InspirePharma S. de
Dec 22, 2021

Glaucoma Trial in Gainesville (timolol maleate and dorzolamide HCl)

Completed
  • Glaucoma
  • timolol maleate and dorzolamide hydrochloride
  • Gainesville, Florida
    University of Florida
Dec 1, 2021

Primary Open-angle Glaucoma Trial in Bogotá, Zapopan (PRO-122, Timolol eye drops, Dorzolamide-Timolol Ophthalmic)

Recruiting
  • Primary Open-angle Glaucoma
  • Bogotá, Bogotá D.C., Colombia
  • +1 more
Dec 22, 2021

Open-angle Glaucoma Trial in Thessaloniki (Drug: dorzolamide/timolol, Drug: latanoprost/timolol, dorzolamide/timolol and

Completed
  • Open-angle Glaucoma
  • Drug: dorzolamide/timolol
  • +3 more
  • Thessaloniki, Greece
    Glaucoma Unit, A University Dept of Ophthalmology
Dec 16, 2020

Diabetic Macular Edema Trial in Tehran (Injections of 1.25 mg of intravitreal bevacizumab with Timolol and Dorzolamide,

Active, not recruiting
  • Diabetic Macular Edema
  • Injections of 1.25 mg of intravitreal bevacizumab with Timolol and Dorzolamide
  • Injections of 1.25 mg of intravitreal bevacizumab with artificial tears
  • Tehran, Iran, Islamic Republic of
    Ophthalmic Research Center
Oct 6, 2021

Glaucoma, Ocular Surface Disease Trial (tafluprost, tafluprost and dorzolamide/timolol)

Completed
  • Glaucoma
  • Ocular Surface Disease
  • (no location specified)
Dec 16, 2020

Neovascular Age-related Macular Degeneration, Wet Macular Degeneration Trial in United States (Dorzolamide-timolol, Artificial

Completed
  • Neovascular Age-related Macular Degeneration
  • Wet Macular Degeneration
  • Dorzolamide-timolol
  • Artificial tears
  • Palo Alto, California
  • +4 more
Jun 5, 2020

Glaucoma Trial in Miami (Latanoprost, Bimatoprost, Travoprost)

Active, not recruiting
  • Glaucoma
  • Miami, Florida
    Bascom Palmer Eye Institute - University of Miami
Oct 7, 2021

Wet Macular Degeneration, Age-related Macular Degeneration, Diabetic Macular Edema Trial in Philadelphia (Dorzolamide-timolol)

Completed
  • Wet Macular Degeneration
  • +3 more
  • Dorzolamide-timolol
  • Philadelphia, Pennsylvania
    Wills Eye Hospital / Mid Atlantic Retina
Dec 1, 2019

Glaucoma, Open Angle, Ocular Hypertension Trial in Worldwide (Xalacom, Cosopt)

Completed
  • Glaucoma, Open Angle
  • Ocular Hypertension
  • Caen, France
  • +24 more
Feb 17, 2021

Primary Open Angle Glaucoma, Ocular Hypertension Trial in Montemorelos (dorzolamide-timolol-brimonidine)

Completed
  • Primary Open Angle Glaucoma
  • Ocular Hypertension
  • Montemorelos, Nuevo Leon, Mexico
    Instituto de la Visión. Hospital Universitario La Carlota. Unive
Jun 6, 2019

Primary Open Angle Glaucoma of Both Eyes Trial in Kazan (Dorzotimol eye drops, 20 mg/mL + 5 mg/mL, Cosopt eye drops, 20 mg/mL +

Completed
  • Primary Open Angle Glaucoma of Both Eyes
  • Dorzotimol eye drops, 20 mg/mL + 5 mg/mL
  • Cosopt eye drops, 20 mg/mL + 5 mg/mL
  • Kazan, Russian Federation
    Republican Clinical Ophthalmological Hospital of the Ministry of
Jul 26, 2023

Primary Open Angle Glaucoma, Ocular Hypertension Trial (PRO-122, Krytantek Ofteno®)

Completed
  • Primary Open Angle Glaucoma
  • Ocular Hypertension
  • (no location specified)
Nov 20, 2019

Glaucoma Trial in Guadalajara (PRO-122, Krytantek Ofteno®)

Completed
  • Glaucoma
  • Guadalajara, Jalisco, Mexico
    Unidad Clínica de Bioequivalencia, S. de R.L. de C.V.
Dec 12, 2019

Macular Hole, Retinal Detachment Trial in Philadelphia (Dorzolamide 2%-timolol 0.5% topical eyedrops)

Completed
  • Macular Hole
  • Retinal Detachment
  • Dorzolamide 2%-timolol 0.5% topical eyedrops
  • Philadelphia, Pennsylvania
    Wills Eye Institute
Aug 13, 2019

Glaucoma, Open-Angle Trial (Brimonidine Tartrate, Dorzolamide (as Dorzolamide Hydrochloride) 20 Mg/mL and Timolol (as Timolol

Completed
  • Glaucoma, Open-Angle
  • Brimonidine Tartrate
  • +5 more
  • (no location specified)
May 24, 2019

Glaucoma Trial in Indianapolis (fixed combination of brimonidine tartrate 0.2% timolol maleate 0.5% ophthalmic solution, fixed

Completed
  • Glaucoma
  • fixed combination of brimonidine tartrate 0.2% timolol maleate 0.5% ophthalmic solution
  • fixed combination of dorzolamide hydrochloride timolol maleate ophthalmic solution
  • Indianapolis, Indiana
    (unnamed)
Apr 10, 2019

Glaucoma, Ocular Surface Disease Trial in Thessaloniki (Assessment of ocular surface staining (Oxford score 0-15 scale), mean

Completed
  • Glaucoma
  • Ocular Surface Disease
  • Assessment of ocular surface staining (Oxford score 0-15 scale)
  • mean diurnal intraocular pressure-lowering
  • Thessaloniki, Greece
    University Department of Ophthalmology
Dec 16, 2020

Patients Who Received EGFR-TKI for the Treatment of NSCLC and Developed Paronychia (Affecting Fingernails, Toenails or Both)

Recruiting
  • Patients Who Received EGFR-TKI for the Treatment of Non-small Cell Lung Cancer and Developed Paronychia (Affecting Fingernails, Toenails or Both)
  • Topical Timolol
  • Hong Kong, Hong Kong
    Queen Mary Hospital
Nov 14, 2023

Cataract, Glaucoma, Ocular Hypertension Trial in Glendale (Bimatoprost Implant System (High Dose), Bimatoprost Implant System

Recruiting
  • Cataract
  • +2 more
  • Bimatoprost Implant System (High Dose)
  • +4 more
  • Glendale, Arizona
    Arizona Advanced Eye Research Institute
Nov 8, 2023

Glaucoma Open-Angle Primary, Ocular Hypertension Trial in Albany (H-1337 0.6%, H-1337 1.0%, H-1337 Placebo)

Not yet recruiting
  • Glaucoma Open-Angle Primary
  • Ocular Hypertension
  • H-1337 0.6%
  • +3 more
  • Albany, Georgia
    Dixon Eye Care
Jun 12, 2023

Infantile Hemangioma Trial in Houston (Propranolol three times a day, Propranolol twice a day, Timolol)

Recruiting
  • Infantile Hemangioma
  • Propranolol three times a day
  • +2 more
  • Houston, Texas
    The University of Texas Health Science Center at Houston
Jul 28, 2022

Open-Angle Glaucoma, Ocular Hypertension Trial in Newport Beach (Nebivolol Ophthalmic Suspension 1 Percent, Nebivolol Ophthalmic

Completed
  • Open-Angle Glaucoma
  • Ocular Hypertension
  • Nebivolol Ophthalmic Suspension 1 Percent
  • +3 more
  • Newport Beach, California
    Site 0012
Jul 18, 2022

Acne Scars - Mixed Atrophic and Hypertrophic Trial (microneedling, microneedling with topical timolol 0.5%)

Not yet recruiting
  • Acne Scars - Mixed Atrophic and Hypertrophic
  • microneedling
  • microneedling with topical timolol 0.5%
  • (no location specified)
Oct 25, 2022